Innovative Technology in the Medical Device and Regenerative Medicine Industry
Kensey Nash Corporation is a medical device company known for providing
innovative product development and advanced technology in our industry for a wide range of
medical procedures. The Company has expanded well beyond its beginnings in
vascular puncture closure technology and today, through its biomaterials and endovascular
business units supplies an extensive range of products into multiple medical
markets such as regenerative medicine and medical device manufacturing.
As the inventor of the Angio-Seal™ Vascular Closure Device, now manufactured, marketed and sold by St. Jude Medical Inc., Kensey Nash Corporation pioneered the concept of arterial closure -- establishing itself as an innovative leader in cardiovascular technology. That innovative ability enabled the Company to expand its biomaterials technology and it now designs, develops and manufactures biomaterials-based products which are commercially available in the fields of orthopedics (including sports medicine and spine), cardiology, drug delivery, oral care, general surgery, trauma and wound care. These biomaterial based components include synthetic polymers, collagen, polysaccharides and ceramics which are turned into novel products in the areas of soft and hard tissue fixation, soft and hard tissue regeneration and biologic drug carriers which are manufactured for and distributed by Fortune 100 companies and emerging new technology firms alike.
Kensey Nash has developed a platform of proven endovascular products for treatment of thrombus and chronic total occlusion. The QuickCat™ Extraction Catheter is used in a process that removes soft, fresh thrombus. The ThromCat™ Mechanical Thrombectomy Catheter System utilizes HeliFlex™ technology to flush, macerate and extract thrombus while the Safe-Cross™ Radio Frequency Total Occlusion Crossing System utilizes guide wire technology to cross and recanalize Chronic Total Occlusions (CTOs). While this business was sold to Spectranetics, Inc. in May 2008, the company continues to manufacture and develop these products under agreement with Spectranectics, allowing for its continued participation in the future growth and success of these products.
Medical Device Supplies & Regenerative Medicine Leaders
Kensey Nash is a leader in medical device, regenerative medicine and resorbable biomaterials technologies. Kensey Nash constructs and manufactures medical device products for use in curative surgical and diagnostic procedures. Kensey Nash has dedicated itself to development of pioneering products and services for the medical community. We continue to be one of the largest innovators in the field of regenerative and resorbable medical implants. Please explore our site to view examples of our various products and services.
In addition to our commercialized products, Kensey Nash has a dedicated research and development (R&D) program that has created significant intellectual property and built multiple technology platforms based on both natural and synthetic polymers. Our collagen, porous polymer and molded polymer technologies have been used in the creation of innovative products for replacement of arteries and veins, regeneration of bone and cartilage, repair and reinforcement of damaged tissues as well as delivery of drugs, cells and growth factors. Kensey Nash has experienced development teams knowledgeable in all areas necessary to bring an idea from concept to commercialization, including design controls, pre-clinical and clinical testing, regulatory approvals, manufacturing, and ongoing quality control test requirements.
We pride ourselves on superior customer service and appreciate the opportunity to help you! For more information, please call us at (484) 713-2100 or use our simple contact form to request information.
